Ignite Creation Date:
2024-05-06 @ 1:32 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04051944
Status:
COMPLETED
Last Update Posted:
2022-11-03
First Post:
2019-08-08
Brief Title:
A Study to Assess Long-term Safety Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma